Evaluation of an Endoscopic Suturing System for Tissue Apposition in Colonic Polypectomy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00553436|
Recruitment Status : Completed
First Posted : November 5, 2007
Results First Posted : March 26, 2010
Last Update Posted : April 27, 2010
|Condition or disease||Intervention/treatment||Phase|
|Polyps||Device: Tissue Apposition System (TAS) Device||Not Applicable|
Polypectomy is the medical term for removing polyps. Polyps are abnormal like growths that protrude into the lining of the bowel. Because a polyp cannot always be removed by a snare, the usual and simplest method, (for example, it may be too flat), a doctor (colorectal surgeon) may perform a polypectomy using a technique called Endoscopic Mucosal Resection (EMR). Endoscopic Mucosal Resection (EMR)is based on the concept that endoscopy (looking at the inside of your colon with an instrument called a colonoscope) provides visualization and access to the innermost lining of the gastrointestinal tract, where a polyp originates. The Endoscopic Mucosal Resection (EMR)performed during this study will be standard of care according to the current practice at University Hospitals of Cleveland.
Following polyp removal, the study procedure will be performed. A medical device is being evaluated to help with this procedure by closing the wound that remains after the polyp is removed without performing an open surgical operation. This involves suturing (sewing) the tissue back together with a Tissue Apposition System (TAS). This is also called tissue approximation. The sewing device being evaluated has been cleared by the Food and Drug Administration (FDA).
Up to 20 men and women, at least 21 years of age, requiring removal of a colonic or rectal polyp that cannot be removed by traditional colonic polypectomy, will be asked to enroll in the study. Following polyp removal, these patients will have the remaining tissue area closed using the study sewing device. Participation in this study will last approximately three months.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||7 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Evaluation of an Endoscopic Suturing System for Tissue Apposition in Colonic Polypectomy|
|Study Start Date :||November 2007|
|Actual Primary Completion Date :||April 2009|
|Actual Study Completion Date :||April 2009|
Experimental: Enrolled Subjects treated with TAS device
All enrolled subjects treated with the Tissue Apposition System (TAS) device
Device: Tissue Apposition System (TAS) Device
Closure of defect following polypectomy using the Tissue Apposition System (TAS) Device.
- Numbers of Participants With Successful Deployment of Tissue Apposition System (TAS) [ Time Frame: At The Time of Surgery ]Number of enrolled subjects (participants) treated with successful deployment of the Tissue Apposition System (TAS) device.
- Numbers of Participants With Successful Deployments of Tissue Anchors and Associated Knotting Element for Tissue Closure Post-Endoscopic Mucosal Resection (EMR) Tissue Apposition. [ Time Frame: 3 month follow-up ]The total number of participants with successful deployments of tissue anchors and associated knotting elements for tissue closure post-Endoscopic Mucosal Resection (EMR) tissue apposition and achieving defect closure.
- Number of Participants With Durable Tissue Appositions at Three Months Post-Endoscopic Mucosal Resection (EMR) Tissue Apposition [ Time Frame: 3 month follow-up ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00553436
|United States, Ohio|
|University Hospitals, Case Medical Center|
|Cleveland, Ohio, United States, 44106|
|Principal Investigator:||Conor P Delaney, MD MCh PhD FRCSI FACS||University Hospitals Cleveland Medical Center|